Literature DB >> 24229706

To die or not to die: Sema3E rules the game.

Luca Tamagnone1, Michael Rehman.   

Abstract

Sema3E, a ligand for PlexinD1, controls angiogenesis and promotes cancer invasion and metastasis. In this issue of Cancer Cell, Luchino and colleagues report that Sema3E also ensures breast cancer cell viability by blocking a previously unknown proapoptotic signaling cascade elicited by unliganded PlexinD1, thus behaving as a "dependence receptor."
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24229706     DOI： 10.1016/j.ccr.2013.10.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  5 in total

Review 1.  EMT-Inducing Molecular Factors in Gynecological Cancers.

Authors:  Loredana Campo; Catherine Zhang; Eun-Kyoung Breuer
Journal:  Biomed Res Int       Date:  2015-08-19       Impact factor: 3.411

2.  Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA.

Authors:  Yiming Li; Cong Xu; Bo Sun; Fangjing Zhong; Momo Cao; Lianyue Yang
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

3.  Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.

Authors:  Hani Al-Shareef; Shin-Ichiro Hiraoka; Noriaki Tanaka; Yosuke Shogen; Atsushi-Doksa Lee; Sanam Bakhshishayan; Mikihiko Kogo
Journal:  Oncol Rep       Date:  2016-09-21       Impact factor: 3.906

4.  A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.

Authors:  E Calura; S Pizzini; A Bisognin; A Coppe; G Sales; E Gaffo; T Fanelli; C Mannarelli; R Zini; R Norfo; V Pennucci; R Manfredini; C Romualdi; P Guglielmelli; A M Vannucchi; S Bortoluzzi
Journal:  Blood Cancer J       Date:  2016-06-24       Impact factor: 11.037

5.  A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.

Authors:  Xiaoli Zhang; Brett Klamer; Jin Li; Soledad Fernandez; Lang Li
Journal:  BMC Med Genomics       Date:  2020-04-03       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.